Batimastat

DESCRIPTION

A broad spectrum inhibitor of MMPs, with IC50 values of 1-5 nM for all MMPs tested, including MMP-1, -2, -3, -7, -9, -13, and -14; also potently inhibits TACE (IC50 = 14.9 nM); has anti-proliferative, anti-invasive, and anti-metastatic actions that are relevant, in particular, to cancer

DETAILS

Inchi: InChI=1S/C23H31N3O4S2/c1-15(2)12-17(18(22(28)26-30)14-32-20-10-7-11-31-20)21(27)25-19(23(29)24-3)13-16-8-5-4-6-9-16/h4-11,15,17-19,30H,12-14H2,1-3H3,(H,24,29)(H,25,27)(H,26,28)/t17-,18+,19+/m1/s1
Purity: ≥98%
Raptas: Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Research Area|Cancer|Cell Migration & Metastasis
Smiles: O=C(N[C@@H](CC1=CC=CC=C1)C(NC)=O)[C@H](CC(C)C)[C@@H](C(NO)=O)CSC2=CC=CS2
Inchikey: XFILPEOLDIKJHX-QYZOEREBSA-N
Cas Number: 130370-60-4
Formulation: A crystalline solid
Storage Temp: -20
Shipping Temp: -20
Formula Markup: C23H31N3O4S2
Formula Weight: 477.6
Shelf Life Days: 1460